104 related articles for article (PubMed ID: 8913935)
41. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN
Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483
[TBL] [Abstract][Full Text] [Related]
42. Cytokines in rheumatoid arthritis: is it all TNF-alpha?
Miossec P
Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):675-8. PubMed ID: 11502074
[TBL] [Abstract][Full Text] [Related]
43. [Blockade of TNFalpha--new therapeutic principle in severe rheumatoid arthritis].
Larsson P; Bratt J; Harju A; van Vollenhoven R; Klareskog L
Lakartidningen; 2001 Feb; 98(8):828-31. PubMed ID: 11265568
[TBL] [Abstract][Full Text] [Related]
44. The mode of action of cytokine inhibitors.
Arend WP
J Rheumatol Suppl; 2002 Sep; 65():16-21. PubMed ID: 12236617
[TBL] [Abstract][Full Text] [Related]
45. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
Meyer O
Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
[TBL] [Abstract][Full Text] [Related]
46. Role of cytokines in rheumatoid arthritis.
Feldmann M; Brennan FM; Maini RN
Annu Rev Immunol; 1996; 14():397-440. PubMed ID: 8717520
[TBL] [Abstract][Full Text] [Related]
47. [New therapeutic methods against rheumatoid arthritisp6. Antibodies against TNFalpha significant for the progress].
Bondeson J
Lakartidningen; 1997 Jan; 94(1-2):42-5. PubMed ID: 9053603
[TBL] [Abstract][Full Text] [Related]
48. [Anti-TNF-alpha therapy as a new option in treatment of rheumatoid arthritis?].
Leeb BF; Sautner J
Wien Med Wochenschr; 1999; 149(19-20):554-7. PubMed ID: 10637966
[TBL] [Abstract][Full Text] [Related]
49. [Cytokines and their antagonists in the treatment of rheumatoid arthritis].
Klimiuk PA; Sierakowski S
Przegl Lek; 2002; 59(2):108-12. PubMed ID: 12152246
[TBL] [Abstract][Full Text] [Related]
50. [Cytokines in rheumatoid arthritis. I. Proinflammatory cytokines].
Klimiuk PA; Sierakowski S
Pol Merkur Lekarski; 2001 Dec; 11(66):510-3. PubMed ID: 11899850
[TBL] [Abstract][Full Text] [Related]
51. Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?
Dayer JM
J Rheumatol Suppl; 2002 Sep; 65():10-5. PubMed ID: 12236616
[TBL] [Abstract][Full Text] [Related]
52. The TNF-alpha transgenic mouse model of inflammatory arthritis.
Li P; Schwarz EM
Springer Semin Immunopathol; 2003 Aug; 25(1):19-33. PubMed ID: 12904889
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists.
Jazayeri JA; Carroll GJ; Vernallis AB
Int Immunopharmacol; 2010 Jan; 10(1):1-8. PubMed ID: 19804846
[TBL] [Abstract][Full Text] [Related]
54. What have we learnt from targeted anti-TNF therapy?
Feldmann M; Williams RO; Paleolog E
Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i97-99. PubMed ID: 19995756
[TBL] [Abstract][Full Text] [Related]
55. Targeting TNF alpha for the therapy of rheumatoid arthritis.
Maini RN; Elliott M; Brennan FM; Williams RO; Feldmann M
Clin Exp Rheumatol; 1994; 12 Suppl 11():S63-6. PubMed ID: 7768056
[TBL] [Abstract][Full Text] [Related]
56. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.
Camussi G; Lupia E
Drugs; 1998 May; 55(5):613-20. PubMed ID: 9585859
[TBL] [Abstract][Full Text] [Related]
57. Cytokine production in the rheumatoid joint: implications for treatment.
Feldmann M; Brennan FM; Chantry D; Haworth C; Turner M; Abney E; Buchan G; Barrett K; Barkley D; Chu A
Ann Rheum Dis; 1990 Jun; 49 Suppl 1():480-6. PubMed ID: 2197999
[TBL] [Abstract][Full Text] [Related]
58. Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases.
Taylor PC
Mol Biotechnol; 2001 Oct; 19(2):153-68. PubMed ID: 11725485
[TBL] [Abstract][Full Text] [Related]
59. TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
Maini RN; Brennan FM; Williams R; Chu CQ; Cope AP; Gibbons D; Elliott M; Feldmann M
Clin Exp Rheumatol; 1993; 11 Suppl 8():S173-5. PubMed ID: 8391952
[TBL] [Abstract][Full Text] [Related]
60. The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis.
Paleolog E
Expert Opin Investig Drugs; 2003 Jul; 12(7):1087-95. PubMed ID: 12831345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
